Application note: Afucosylated mAb expression & antibody efficacy
Sino Biological’s “FucoFree” eukaryotic expression system provides high-yield and high-throughput afucosylated monoclonal antibody (mAb) production.
List view / Grid view
Sino Biological’s “FucoFree” eukaryotic expression system provides high-yield and high-throughput afucosylated monoclonal antibody (mAb) production.
The pipetting robot, flowbot® ONE, is available with UV light to make clean-up processes easy and effective, enabling you to keep your samples safe.
Strike NGS workflow gold with our broad portfolio of automation solutions, delivering reliable, high-throughput results. But don't take our word for it! Hear from our customer.
Strike NGS workflow gold with our broad portfolio of automation solutions, delivering reliable, high-throughput results. But don't take our word for it! Hear from our customer.
Check out our library of NGS-related webinars from global researchers and industry professionals to explore possibilities with our Biomek automated workstations and Echo acoustic liquid handlers.
Generate accurate data by automating your NGS workflows with Beckman Coulter Life Sciences’ flexible automated liquid handling solutions that deliver reliable results.
Explore how to apply our acoustic and tip-based liquid handling solutions for your NGS workflows in metagenomics, sample QC, RNASeq, microbiome, SARS-CoV 2 to name a few.
Automation solutions from Beckman Coulter Life Sciences alleviate your library prep pain points, whether you need automation for a few samples or a high-throughput solution.
Work with one trusted partner for instruments, software, consumables and service to help keep your laboratory running smoothly. Smooth processes save time, money and maximise your lab’s ROI.
Scientists have published a report on the whole genome sequences of 150 thousand participants in the UK biobank.
Droplet Digital PCR (ddPCR) offers greater accuracy and precision in quantifying viral titer in gene therapies.
Researchers have developed a two-step approach using whole exome sequencing to focus on genes and pathways that predict whether cancer patients will respond to immunotherapy.
A recent whole genome sequencing study has revealed hidden insights into the causes of cancer. In an exclusive article, Dr Andrea Degasperi from the Early Cancer Institute at the University of Cambridge, UK spoke to Drug Target Review's Ria Kakkad about the study's implications and the future of whole genome sequencing.
This infographic will explore Mycoplasma contamination in cell cultures and the best technologies for detection.
Podcast discussion featuring CAR-T Cell therapy development and reviewing current challenges and future potentials for these cell therapies.